Zobrazeno 1 - 10
of 186
pro vyhledávání: '"F Lansigan"'
Autor:
JP Sharman, JM Melear, A Yacoub, SR Fanning, DJ Andorsky, GS Nowakowski, MJ Rummel, F Lansigan, J Li, JR Ahn, M Gharibo, M Coleman
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S73- (2021)
Objectives: The combination of lenalidomide + rituximab (R2) has shown complementary clinical activity and is a tolerable regimen in both untreated and relapsed or refractory (R/R) indolent non-Hodgkin lymphoma (NHL), as well as mantle cell lymphoma
Externí odkaz:
https://doaj.org/article/035c7b2086924f859222e76f61ec7cac
Autor:
F Lansigan, DJ Andorsky, M Coleman, A Yacoub, JMM Md, SR Fanning, KS Kolibaba, C Reynolds, G Nowakowski, M Gharibo, E Ahn, J Li, MJ Rummel, JP Sharman
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S105-S106 (2021)
Objectives: Lenalidomide combined with rituximab (R2) has shown complimentary clinical activity and is a tolerable regimen in both untreated and relapsed or refractory (R/R) patients (pts) with indolent non-Hodgkin lymphoma. Pts with advanced age at
Externí odkaz:
https://doaj.org/article/f31add9cf54d44adb14bad41e86b3617
Autor:
M Coleman, DJ Andorsky, A Yacoub, JM Melear, SR Fanning, KS Kolibaba, F Lansigan, C Reynolds, G Nowakowski, M Gharibo, E Ahn, J Li, MJ Rummel, JP Sharman
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S98- (2021)
Objectives: Relapse is expected when treating patients with follicular lymphoma (FL) and marginal zone lymphoma (MZL), with a shortened response associated with each relapse. Lenalidomide combined with rituximab (R2) has shown enhanced activity, with
Externí odkaz:
https://doaj.org/article/c4a2564782f24e20971aeb2d2c6d05d0
Autor:
M. Shadman, J. Voutsinas, B. Fakhri, S. Khajavian, S. Spurgeon, D. Stephens, A. Skarnbik, A. Mato, C. Broome, A. Gopal, S. Smith, R. Lynch, M. Rainey, S. Kim, O. Barrett-Campbell, E. Hemond, M. Tsang, D. Ermann, N. Malakhov, D. Rao, M. Shakib Azar, B. Morrigan, A. Chauhan, T. Plate, T. Gooley, K. Ryan, F. Lansigan, B. Hill, G. Pongas, S. Parikh, L. Roeker, J. Allan, R. Cheng, C. Ujjani
Publikováno v:
HemaSphere, Vol 6, Pp 573-574 (2022)
Externí odkaz:
https://doaj.org/article/78a563d22b8f415280fdfeec96f5a986
Autor:
A. R. Mato, B. S. Manzoor, C. C. Coombs, N. Lamanna, H. H. Tuncer, J. R. Brown, L. E. Roeker, M. Shadman, J. N. Allan, C. Ujjani, B. Eichhorst, L. Leslie, I. Fleury, H. Alhasani, J. Rhodes, B. T. Hill, P. M. Barr, A. Skarbnik, M. S. Davids, R. Bannerji, M. Fuldeore, F. Lansigan, A. Schuh, L. Pearson, C. P. Fox, I. Pivneva, L. Popadic, A. Guerin, T. A. Eyre
Publikováno v:
HemaSphere, Vol 6, Pp 569-570 (2022)
Externí odkaz:
https://doaj.org/article/8f7acc4b3eac4168becfee180d24abb1
Autor:
F. Lansigan, D. J. Andorsky, M. Coleman, A. Yacoub, J. M. Melear, S. R. Fanning, K. S. Kolibaba, C. Reynolds, G. S. Nowakowski, M. Gharibo, J. R. Ahn, J. Li, M. J. Rummel, J. P. Sharman
Publikováno v:
HemaSphere, Vol 6, Pp 1043-1044 (2022)
Externí odkaz:
https://doaj.org/article/9752c84003414ff5909ac9baa7e851ba
Autor:
J. Butonzi, V. Forbes, C. Kigonya, F. Lansigan, T. Davis, K. Figueroa, D. Ruhangaza, K. Shabani, P. Nininahazwe, E. Nkunsi, O. Habimana, j. . Haley, L. Buswell, C. Costa, A. Hill, P. Sharma, C. Hanna, A. Fehr, B. DeBoer, P. Park, F. Sebahungu, E. Mpanumusingo, C. Shyirambere, T. Mpunga, L. N. Shulman, M. Chamberlin
Publikováno v:
Rwanda Medical Journal, Vol 76, Iss 4, Pp 1-5 (2019)
BACKGROUND: To meet the rising demand for cancer care in low- and middle-income countries (LMICs), educational partnerships are needed. The Geisel School of Medicine at Dartmouth (GSMD) Hematology-Oncology Fellowship Program (HOFP) piloted a bi-annua
Externí odkaz:
https://doaj.org/article/cc0ba6f9280d41de992a10975e094650
Autor:
D.J. Andorsky, M. Coleman, A. Yacoub, J.M. Melear, S.R. Fanning, K.S. Kolibaba, F. Lansigan, C. Reynolds, G. Nowakowski, A.L. Et
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 222- (2020)
Externí odkaz:
https://doaj.org/article/194af21a15304370a7c04678fc09775f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.